ST Pharm Co Ltd
KOSDAQ:237690
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
S
|
ST Pharm Co Ltd
KOSDAQ:237690
|
KR |
|
A
|
Advanced Oxygen Technologies Inc
OTC:AOXY
|
US |
|
Esperion Therapeutics Inc
NASDAQ:ESPR
|
US |
|
R
|
Ramsay Generale de Sante SA
PAR:GDS
|
FR |
|
S
|
SailPoint Technologies Holdings Inc
F:SV7
|
US |
|
Methanex Corp
TSX:MX
|
CA |
|
Banco Pine SA
BOVESPA:PINE4
|
BR |
Wall Street
Price Targets
Price Targets Summary
ST Pharm Co Ltd
According to Wall Street analysts, the average 1-year price target for ST Pharm Co Ltd is 163 795 KRW with a low forecast of 101 000 KRW and a high forecast of 220 500 KRW.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is ST Pharm Co Ltd's stock price target?
Price Target
163 795
KRW
According to Wall Street analysts, the average 1-year price target for ST Pharm Co Ltd is 163 795 KRW with a low forecast of 101 000 KRW and a high forecast of 220 500 KRW.
What is ST Pharm Co Ltd's Revenue forecast?
Projected CAGR
21%
For the last 10 years the compound annual growth rate for ST Pharm Co Ltd's revenue is 11%. The projected CAGR for the next 4 years is 21%.
What is ST Pharm Co Ltd's Operating Income forecast?
Projected CAGR
48%
For the last 10 years the compound annual growth rate for ST Pharm Co Ltd's operating income is 11%. The projected CAGR for the next 4 years is 48%.
What is ST Pharm Co Ltd's Net Income forecast?
Projected CAGR
27%
For the last 10 years the compound annual growth rate for ST Pharm Co Ltd's net income is 20%. The projected CAGR for the next 4 years is 27%.
